NASA's Fisk Vows To Lift Space Science Out Of Its Doldrums

Sometime in the next few weeks, the space shuttle Discovery should lift off into orbit. The mission will end a long and agonizing drought for the United States space program, and no group will be more eagerly watching than the nation's space scientists. For on Discovery's rocket plumes will be riding the hopes for launching such key science payloads as the Hubble space telescope, the Galileo planetary probe, and the Gamma Ray Observatory. But ending what many have called a "crisis" in space scie

Written byJohn Carey
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

But ending what many have called a "crisis" in space science— the result of the long failure to launch—requires more than just a functioning shuttle. It will also take, at the very least, a fleet of expend able rockets and a steady stream of new mission starts.

One man who believes that the U.S. is on the verge of a new, productive era in space is Lennard A. Fisk, NASA'S associate administrator for space science and applications. Since taking over the agency's office of space science in April 1987, Fisk has put together an ambitious, long-range plan, with some 35 missions scheduled for the next five years alone.

Will these missions actually fly? Can they lift U.S. space science out of its doldrums? And is the shuttle the right launch vehicle? Fisk, an astrophysicist who spent five years as vice president for research at the University of New Hampshire, addressed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies